Walgreens Boots Alliance on Thursday exceeded fiscal fourth-quarter sales expectations, as the drugstore chain turns itself into a more health-care focused company.
The drugstore chain said it anticipates full-year adjusted earnings per share of $4.45 to $4.65 in the coming fiscal year, which is about in line with what Wall Street expected. Yet Walgreens said its business growth will face tough comparisons as it laps strong demand for Covid vaccines and gets hits by the strength of the dollar.
The company’s shares were up more than 5% Thursday morning.
Walgreens reported its earnings on the same day as a hotter-than-expected inflation report from the government. On a call with investors,…